Market
Access

Ensuring Access to the Right Products for Health Workers and Clients Alike

The availability of new health products and technologies, such as medicines, vaccines, and diagnostic tests, is often delayed in low- and middle-income countries. Many health facilities struggle to meet clients’ needs due to a lack of even basic supplies. And when products and technologies are available, they are often poor quality, require highly skilled personnel, or come at high costs. Jhpiego recognizes the urgent need for health products and technologies to be more accessible, affordable, and delivered swiftly so that frontline health workers can perform their duties effectively and empower clients to take control of their health. Our goal is to ensure that health systems provide health workers with the necessary resources, rather than forcing them to work with inadequate supplies.

Our Approach

Assess

We adopt a systematic approach to identify specific barriers to access for each product across the value chain. These barriers include policy barriers, market barriers (pricing, product quality, and design), health system barriers, service delivery barriers, and supply chain barriers.

Diagnose

We analyze the root causes of access barriers by examining all levels of the health system, from the market to the health system and point-of-delivery levels.

  • We evaluate product availability at each level and ask key questions. For instance, are products present in the market? If they are available, can they be found within the country’s public health system? Are they accessible at the locations where care is provided, such as facilities, communities, and pharmacies? If any of these levels show a lack of availability, we investigate the reasons and explore solutions to address the issue.

Plan

We develop targeted plans to tackle each unique barrier, prioritizing the integration of our efforts within existing systems and focusing on capacity building to create sustainable and scalable solutions.

  • Jhpiego collaborates with regional entities and governments, providing technical assistance to enhance systems, mechanisms, and institutional capacity as necessary. For example, rather than directly purchasing new products through a sponsored project, we support national governments through technical assistance to secure funding and procure the products themselves at affordable prices. This approach fosters a sustainable system that ensures long-term availability of health products and technologies across the board.

Act

We then implement these plans, taking proactive steps to elevate and empower frontline health workers and clients.

  • Our efforts ensure that essential health products and technologies are accessible at points of care, while also prioritizing those that enhance the capabilities of health workers and empower clients. These include point-of-care diagnostics that assist health workers in making real-time clinical decisions, user-friendly medical devices for nurses and community health workers, and heat-stable medications that do not require refrigeration.

Program Experts

Naoko Doi

Team Lead for Market Access

Unitaid Awards Jhpiego a Grant to Combat Antimalarial Drug Resistance in Africa

The four-year, $26.5 million grant will help minimize the impact of antimalarial drug resistance.